A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT07502222 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07502222
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-07
- Primary completion
- 2027-11-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.